Novartis Pharma Inc.
Basic information
- Head office
- 1-23-1 Toranomon Hills Mori Tower, Toranomon, Minato-ku, Tokyo 105-6333, Japan
- Chief executive
- ジョンポール・プリシーノ(John Paul Pullicino)
- Capital
- 100,000,000
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 1997-04-01
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Novartis Science Promotion Foundation |
Network
History
In 1758, Johann Rudolf Geigy-Gemuseus (1733–1793) founded the trading company J.R. Geigy in Basel, Switzerland, dealing with all kinds of materials, chemicals, dyes, and pharmaceuticals.![]()
In 1859, Alexander Clavel (1805–1873) began producing the synthetic dye fuchsine at his silk dyeing factory in Basel, Switzerland.![]()
In 1886, Alfred Kern (1850–1893) and Edouard Sandoz (1853–1928) founded the chemical company Kern & Sandoz in Basel, Switzerland. Their first dyes were alizarin blue and auramine.![]()
In 1970, Louis von Planta, president of Geigy, and Robert Käppeli, president of Ciba, shook hands to complete the merger of Ciba-Geigy.![]()
In 1996, the merger of Sandoz and Ciba-Geigy created Novartis, one of the world's largest healthcare companies. This image was taken on February 3, 1997, showing the new logo being installed at Novartis' St. Johann in Basel.![]()
In 1996, the merger of Sandoz and Ciba-Geigy established Novartis, one of the world's largest healthcare companies.![]()
In 2002, Novartis Biomedical Research Institute (NIBR) was established in Cambridge, Massachusetts, USA, integrating and strengthening a global research network.![]()
News
There is no news.